ArticleWorld journal of hepatology2023

Glecaprevir/pibrentasvir + sofosbuvir for post-liver transplant recurrent hepatitis C virus treatment.

Rishi Arora et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.